Fig. 3. REZPEG efficacy in PsO patients.

Reduction in PASI scores from baseline in patients with PsO after 12 weeks of 24 μg/kg REZPEG treatment (red circles) compared to placebo (grey circles) administered once every 2 weeks for 12 weeks. Data shown as mean percent change from baseline ± SEM. Number of subjects at each time point shown in Supplementary Table 8. PASI, psoriasis area and severity index; PsO, psoriasis; SEM, standard error of the mean. Source data are provided as a Source Data file.